Cleerly to Showcase New AI-QCT Research at SCCT2025 Annual Meeting
New Insights on AI-Quantitative Coronary CT (AI-QCT) Data to be Shared in Montreal, July 17-20, 2025
Cleerly is aware of the lawsuit filed by Heartflow. We are confident in our extensive and well-established intellectual property portfolio and the originality of our technology.
Cleerly has published landmark clinical science that has redefined how cardiovascular disease is understood and treated, which has formed the basis of our novel technologies that provide physicians with actionable insights into their patients’ heart health.
Cleerly was founded on a mission to create a world without heart attacks, and we have never been more focused in our mission and committed to the patients and physicians who count on us.
For any questions, please reach out to press@cleerlyhealth.com
New Insights on AI-Quantitative Coronary CT (AI-QCT) Data to be Shared in Montreal, July 17-20, 2025
Becomes First Clinic in Area to Offer Cleerly AI Heart Disease Analyses
Strategic promotions strengthen Cleerly's executive team as company accelerates growth
New partnership aims to optimize appropriate procedures and transform cardiac care with AI-powered imaging technology